Mesoblast
MESO----
Mesoblast (MESO)
Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Mesoblast Analyst Rating
View MoreForecast & Rating
Jul 14, 2026Price forecast
$35.00140.38%
Forecast & RatingBuy
3analysts
- Strong buy33.33%
- Buy66.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Simplywall · 2 hours ago
Australian Stocks Trading Below Fair Value Based On Cash Flows
- Simplywall · 2 days ago, 12:07 PM
Why Retail Investors Are Tracking These 3 Founder Led Australian Stocks Today
- Simplywall · Jul 20 at 04:08 PM
3 Founder Led Stocks With Real Management Alignment Investors May Want To Watch
- Simplywall · Jul 16 at 12:08 AM
Founder Led Stocks For Investors Watching Australian Small Caps Closely
- Tip Ranks · Jul 14 at 02:47 AM
Mesoblast Cancels Over 1.2 Million Lapsed Options
- Unusual Whales · Jul 13 at 07:37 PM
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
